Skip to main content
Equibles
NUVB logo

NUVB · Nuvation Bio Inc. · Analyst Estimates

Track NUVB — free

Use NUVB with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NUVB.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.57 -0.13 (-2.77%) At close · Oct 23
Russell 2000 member Rebalance outlook locked
Market Cap
$1.60B
Shares
351.12M
Volume · Oct 23 3.19M Avg daily vol (3M) 5.41M

Analyst Estimates

Compare analyst forecasts for Nuvation Bio Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-24 03:08 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.29
-0.29
-0.29
2
-0.29
-0.29
-0.29
-0.28
1
1
0
0
Revenue
USD
Publication date not stated
176.21M
194.60M
220.76M
13
 — — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.08
-0.015
0.05
2
-0.06
-0.06
-0.06
-0.06
1
1
0
0
Revenue
USD
Publication date not stated
216.86M
275.55M
354.56M
13
 — — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.13
-0.10
-0.09
3
-0.09
-0.09
-0.09
-0.11
1
1
0
0
Revenue
USD
Publication date not stated
27.74M
34.42M
39.80M
13
 — — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.09
-0.09
-0.09
2
-0.09
-0.09
-0.09
-0.09
1
1
0
0
Revenue
USD
Publication date not stated
33.42M
45.26M
69.09M
13
 — — — — — — — —
Key facts CIK 1811063 CUSIP 67080N101 13F (30d) 30 filings 30 filers Visit website Investor relations